Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: A relative survival analysis from Finland

International Journal of Cancer

Volumn 93, Issue 3, 2001, Pages 368-372

  Eerola, Hannaleena ^a   Vahteristo, Pia ^a   Sarantaus, Laura ^a   Kyyrönen, Pentti ^b   Pyrhönen, Seppo ^a,c   Blomqvist, Carl ^a,d   Pukkala, Eero ^b   Nevanlinna, Heli ^a   Sankila, Risto ^e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

BRCA1; BRCA2; Breast cancer; Familial; Hereditary; Survival

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENE PRODUCT;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FAMILIAL CANCER; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

ADOLESCENT; ADULT; BRCA2 PROTEIN; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENES, BRCA1; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PEDIGREE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 0035427105     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1341     Document Type: Article

References (35)

1. Proportion of breast cancer cases in the United States explained by well-established risk factors
2. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
3. Mutations in BRCA1 and BRCA2 in breast cancer families, are there more breast cancer-susceptibility genes?
4. BRCA2 in American families with 4 or more cases of breast or ovarian cancer, recurrent novel mutations, variable expression, penetrance, and possibility of families whose cancer is not attributable to BRCA1 or BRCA2
5. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes
6. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
7. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
8. The Influence of familial hereditary factors on the prognosis of breast cancer
9. Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?
10. Hereditary breast cancer. Pathobiology, prognosis, BRCA1 and BRCA2 gene linkage
11. Family history survival in premenopausal breast cancer
12. The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
13. Survival and tumour characteristics of German hereditary breast cancer patients
14. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer
15. Survival in early-onset BRCA1 breast-cancer patients
16. Survival of BRCA1 breast and ovarian cancer patients: A population-based study from Southern Sweden
17. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations
18. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome
19. Response to radiation therapy prognosis in breast cancer patients with BRCA1 and BRCA2 mutations
20. Survival in hereditary breast cancer associated with germline mutations of BRCA2
21. Prognosis and clinical presentation of BRCA2 associated breast cancer
22. Data quality and quality control of a population-based cancer registry
23. How prevalent are breast cancer families and can we trust on the family history reported by the patients?
24. A low proportion of BRCA2 mutations in Finnish breast cancer families
25. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
26. Evidence for founder mutations in Finnish BRCA1 and BRCA2 families
27. Multiple founder effects geographical clustering of BRCA1 and BRCA2 families in Finland
28. Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families
29. Maximum utilisation of the life table method in analyzing survival
30. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
31. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
32. Survival in hereditary breast and colon cancer
33. Better survival rates in patients with MLH1-associated hereditary colorectal cancer